PRELIMINARY LONG-TERM SAFETY, TOLERABILITY, AND ASSESSMENTS OF RENAL FUNCTION OF ADULT FABRY PATIENTS RECEIVING TREATMENT WITH AT1001 (MIGALASTAT HYDROCHLORIDE), A PHARMACOLOGICAL CHAPERONE, FOR UP TO 3 YEARS